Document is current

Article History

Received: 11 April 2024

Accepted: 20 June 2024

First Online: 1 August 2024

Declarations

:

: LK received research grants from Gilead, and has received honoraria for educational lectures from Gilead, Merck, Sharpe & Dohme, and Vertex Pharmaceuticals outside the submitted work. NG acknowledges support of Wellcome Trust Investigator, Collaborative, Equipment, Strategic and Biomedical Resource awards (101873, 200208, 215599, 224323 and 200208 (the latter awarded to Daan van Aalten)) and the MRC (MR/M026663/2) and the MRC Centre for Medical Mycology (MR/N006364/2) for support. KL received consultancy fees from MRM Health and Mundipharma, speaker fees from Pfizer and Gilead, a service fee from Thermo fisher Scientific and TECOmedical and a fee for Advisory Board participation from MSD and Pfizer, JPG has received lecture honoraria from Gilead, MundiPharma and Pfizer, outside of the submitted work. JM reports research grants and/or personal fees for advisor/consultant, and/or speaker/chairman from Gilead Sciences, F2G, Shionogi, Mundipharma, Mundipharma, Takeda, and Basilea. CLF reports research grants and/or personal fees for advisor/consultant, travel and/or speaker/chairman from Gilead, MSD, Pfizer, BioMérieux, F2G, IMMY, Shionogi, Astellas Pharma. SAA reports research grant from Cidara, lecture honoraria from Gilead, and travel grant from Astellas. M. H. received research funding from Gilead, MSD, IMMY, Mundipharma, Scynexis, Melinta, Euroimmune, Shionogi, F2G and Pfizer (all outside of the submitted work). OAC reports grants or contracts from BMBF, Cidara, DZIF, EU-DG RTD, F2G, Gilead, MedPace, MSD, Mundipharma, Octapharma, Pfizer, Scynexis; Consulting fees from Abbvie, AiCuris, Basilea, Biocon, Boston Strategic Partners, Cidara, Seqirus, Gilead, GSK, IQVIA, Janssen, Matinas, MedPace, Menarini, Molecular Partners, MSG-ERC, Mundipharma, Noxxon, Octapharma, Pardes, Partner Therapeutics, Pfizer, PSI, Scynexis, Seres, Shionogi, The Prime Meridian Group; Speaker and lecture honoraria from Abbott, Abbvie, Akademie für Infektionsmedizin, Al-Jazeera Pharmaceuticals/Hikma, amedes, AstraZeneca, Deutscher Ärzteverlag, Gilead, GSK, Grupo Biotoscana/United Medical/Knight, Medscape/WebMD, MedUpdate, MSD, Moderna, Mundipharma, Noscendo, Paul-Martini-Stiftung, Pfizer, Sandoz, Seqirus, Shionogi, streamedup!, Touch Independent, Vitis; Payment for expert testimony Cidara; Participation on a DRC or DSMB for Cidara, IQVIA, Janssen, MedPace, PSI, Pulmocide. The other authors declare no conflict of interest. SW, SS, JFM no conflict of interest.